(EMAILWIRE.COM, March 09, 2019 ) According to research report the amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 150.6 million in 2017, at a CAGR of 2.8%. Factors driving the growth of this market include the high reliability of amniocentesis, increase in the median age of first-time motherhood, and heavy burden of congenital disorders.
The amniocentesis needles market is consolidated in nature due to the presence of a large number of players. The key players in the market are Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).
The key strategy followed by most companies in the amniocentesis needles market is acquisitions. This strategy accounted for the largest share of the overall growth strategies mapped from 2014 to 2017. Some of the leading players who adopted this strategy include Medtronic (Ireland), BD (US), CooperSurgical (US), and Medline (US).
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18541768
Medtronic held the leading position in the amniocentesis needles market in 2016. The company operates in the US, non-US developed countries, and emerging countries. The company offers amniocentesis needles through the patient monitoring & recovery subdivision of the minimally invasive therapy segment. The company acquired Covidien with a view to combine the innovations and extensive capabilities of both companies. However, in 2017, as part of restructuring, the company sold three product lines to Cardinal Health and amniocentesis needles was a part of one of the above product lines.
CooperSurgical ranked second in the amniocentesis needles market in 2016. The company focuses on a broad portfolio of products and services which are focused on women's health, fertility, and diagnostics. The amniocentesis needles are offered through the Wallace brand which it acquired from Smiths Medical in 2016 for USD 168 million. The company manufactures its products in the US, Germany, the Netherlands, and Denmark. It distributes its products across the globe through a network of distributors.
Know more: https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html

Major Market Developments
• In 2018, Medline Industries, Inc. (US) completed the acquisition of Centurion Medical Products (US) to provide a complete set of offerings that complement its minor procedure tray kits and its growing infection prevention focus
• In 2016, CooperSurgical (US) completed the acquisition of Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, to strengthen product portfolio and takeover premier products for women’s health
• In 2017, Medtronic established an innovation center in Chengdu, China to provide advanced training to medical workers in Central and Western China
• In 2016, Medline shifted its corporate headquarters to a new, state-of-the-art facility which is more than double the size of its current space with a view to adapt to the needs of the rapidly changing healthcare.


Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com